Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 71335-2499

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 71335-2499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

Chemical structure of bupropion hydrochloride showing a chlorophenyl group attached to a ketone and an amine functional group with three methyl groups, along with the hydrochloride (HCl) component indicated.*

FDA Label Image

Label (Lbl713352499)

Label for buPROPion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, oral dosage form. The package label shows 30 tablets with NDC 71335-2499-1, labeled by Bryant Ranch Prepack and manufactured by Actavis Laboratories FL, Inc. It includes storage instructions, a warning about use with Zyban, and directs pharmacists to dispense patient package inserts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.